Compares effects of europium doping methods on structural and optical properties of ZnO nanoparticles, highlighting implications for optoelectronic applications.
Zinc oxide nanoparticles (ZnO NPs) were synthesized via a co-precipitation method and doped with Eu 3+ ions using three different approaches: in-situ doping during synthesis (Eu:ZnO(P)), post-synthesis doping (Eu:ZnO(S)), and modification of commercially available ZnO (Eu:ZnO(C)). Structural analysis by X-ray diffraction (XRD) confirmed the preservation of the hexagonal wurtzite phase in all samples, while peak shifts and broadening indicated lattice distortion associated with Eu 3+ incorporation. The crystallite size decreased from 24 to 16 nm for Eu:ZnO(S) and from 61 to 36 nm for Eu:ZnO(C), demonstrating the influence of the doping route on crystal growth. Optical characterization using UV–Vis spectroscopy demonstrated band-gap narrowing from 3.05 to 2.95 eV for Eu:ZnO(C), from 3.00 to 2.90 eV for Eu:ZnO(S), and to 2.85 eV for Eu:ZnO(P). Photoluminescence (PL) analysis revealed enhanced emission intensity and a redshift in doped samples, attributed to defect-related states associated with Eu incorporation. Among all samples, Eu:ZnO(S) exhibited the highest PL intensity and a pronounced emission band near 592 nm, highlighting the effectiveness of post-synthesis doping. These findings demonstrate that the doping strategy and nanoparticle origin play a crucial role in tailoring the structural and optical properties of ZnO nanomaterials for potential optoelectronic and photonic applications.
No takes yet. Share an insight, caveat, or question.
Nuriyeva et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: